Lipocine Inc (LPCN)
4.455
-0.34
(-7.19%)
USD |
NASDAQ |
Apr 24, 16:00
4.455
0.00 (0.00%)
After-Hours: 18:45
Lipocine Cash from Operations (Quarterly): -2.022M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.022M |
| September 30, 2023 | -2.606M |
| June 30, 2023 | -3.310M |
| March 31, 2023 | -3.928M |
| December 31, 2022 | -1.839M |
| September 30, 2022 | -3.198M |
| June 30, 2022 | -3.046M |
| March 31, 2022 | -3.885M |
| December 31, 2021 | 8.994M |
| September 30, 2021 | -6.981M |
| June 30, 2021 | -2.363M |
| March 31, 2021 | -4.062M |
| December 31, 2020 | -3.684M |
| September 30, 2020 | -4.164M |
| June 30, 2020 | -4.079M |
| March 31, 2020 | -3.376M |
| December 31, 2019 | -3.308M |
| September 30, 2019 | -2.797M |
| June 30, 2019 | -2.558M |
| March 31, 2019 | -3.003M |
| December 31, 2018 | -2.233M |
| September 30, 2018 | -3.360M |
| June 30, 2018 | -2.740M |
| March 31, 2018 | -3.746M |
| Date | Value |
|---|---|
| December 31, 2017 | -4.297M |
| September 30, 2017 | -4.566M |
| June 30, 2017 | -4.701M |
| March 31, 2017 | -3.139M |
| December 31, 2016 | -2.547M |
| September 30, 2016 | -4.050M |
| June 30, 2016 | -5.176M |
| March 31, 2016 | -6.509M |
| December 31, 2015 | -2.912M |
| September 30, 2015 | -5.558M |
| June 30, 2015 | -3.862M |
| March 31, 2015 | -3.025M |
| December 31, 2014 | -3.963M |
| September 30, 2014 | -2.477M |
| June 30, 2014 | -7.646M |
| March 31, 2014 | -3.218M |
| December 31, 2013 | -4.113M |
| September 30, 2013 | -4.475M |
| June 30, 2013 | -0.0004M |
| March 31, 2013 | -0.0001M |
| December 31, 2012 | 2.076M |
| September 30, 2012 | -2.079M |
| June 30, 2012 | -0.055M |
| March 31, 2012 | -0.0051M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.981M
Minimum
Sep 2021
8.994M
Maximum
Dec 2021
-2.748M
Average
-3.308M
Median
Dec 2019
Cash from Operations (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | -18.97M |
| Eliem Therapeutics Inc | -0.947M |
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.727M |
| Cash from Financing (Quarterly) | -0.0053M |
| Free Cash Flow | -11.88M |
| Free Cash Flow Per Share (Quarterly) | -0.3821 |
| Free Cash Flow to Equity (Quarterly) | -2.032M |
| Free Cash Flow to Firm (Quarterly) | -2.032M |
| Free Cash Flow Yield | -50.67% |